The term 'conformal therapy' can really be applied to any radiotherapy technique which attempts to improve the dose distribution in tumour and normal tissue, such that the therapeutic gain is enhanced. In other words, it is any process by which the high dose volume is made to conform more closely to the ideal target volume. There is nothing new about this approach which actually underpins all traditional radiotherapy planning techniques. What is new is the burgeoning technology which has revolutionised the possibilities in terms of the extent to which those aims can be pursued and the precision with which they can be carried out.
In conventional external beam radiotherapy planning, the limits of the target volume are defined in two dimensions on any one particular simulator radiograph view. Bony landmarks provide the main anatomical reference points for determining the position of normal tissue structures and tumour extent. The number, shape, size and position of the radiotherapy beams are selected optimally to deliver the prescribed dose to the target volume, aiming to keep the variation in dose to within 10%. However, the assessment of the dose distribution is usually based on a single transaxial plan, conventionally in the middle of the volume, which obviously fails to demonstrate dose inhomogeneities throughout the entire treatment volume. This applies both to the target volume where cold spots are a particular concern with regard to tumour control and to normal tissue structures where hot spots might indicate future morbidity.
The availability of computerised tomography (CT) imaging really established the possibility of three-dimensional planning, allowing an appreciation of the anatomical relations throughout the treatment length. However, this information could not be fully utilised until it was possible to link the CT data directly to a radiotherapy planning system. The application of computer technology has made this a reality and has been the major contributing factor in realising the long held aspirations behind conformal therapy. Although most development effort has focused on external photon beam therapy, the systems devised are also being applied to electron beam therapy, brachytherapy and combinations of these.
But this is just the starting point. (Brahme, 1987) .
The second requirement of conformal therapy, improved dose distribution within the target volume, is also facilitated by dynamic therapy. A simple example of this is the use of the computer-controlled independent collimator action to produce the equivalent of a wedged field. This is done by moving the appropriate collimator across the field with the result that the beam is attenuated in the same way as is achieved by introducing a manual wedge.
Selection of the optimal conformal plan for any given patient requires the clinician to be able to assimilate an enormous quantity of data. The ability to reconstruct CT data, with superimposition of the isodoses, in any chosen plan facilitates both the ordering and interpretation of this information. However, the development of analytical tools such as dose-volume histograms has made it easier to evaluate, and directly compare, treatment plans. Dose-volume histograms are a means of graphically summarising dose distribution information throughout a normal tissue structure or target volume by plotting percentage volumes of tissue against radiation dose levels. By comparing dose-volume histograms for competing plans, an immediate appreciation of the benefits and shortcomings can be ascertained.
Is it worth it?
The attractions of conformal therapy for clinicians and physicists are obvious, as exemplified by the explosion of interest and activity in the field. However, there has been very little in the way of well-designed evaluation of the components, or the overall achievement, of the technique. This is essential -conformal therapy is not an assured winner in clinical terms, but is a definite absorber of resources from the point of view of capital expenditure and manpower.
The core danger is that without adequate monitoring of the precision and accuracy of the components of the technique, in certain situations, local control may in fact be worse. One concern is that over-reliance on imaging techniques to define tumour extent, together with a commendable enthusiasm to spare normal tissues, may result in inadequate treatment margins. This potential risk may be compounded by inaccuracy in the daily treatment set-up such that an area at the edge of the treatment volume may be consistently underdosed. No matter how elegant and sophisticated the treatment plan, success is unlikely if it is applied to a tense, anxious or pain-ridden patient who cannot maintain the same position from day to day, or indeed for the duration of each daily treatment. Currently, a great deal of effort, worldwide, is being put into developing systems which image the patient during treatment so that variation in patient positioning and/or machine alignment can be monitored and corrected. However, there must be assurance that all the elements of the planning and treatment process have an equivalent degree of accuracy and that such errors as are unavoidable are taken into account when designing the plan. This means that each of the technical components of the process must be individually validated and then the sequence tested as a whole.
Technical precision having been ensured, the next step is to address clinical and biological questions on the basis of a comparison with the best available standard radiation treatment techniques. This requires well designed prospective studies which will clearly identify the differences, and the size and frequency of those differences, between the two techniques (Tait et al., 1988) . If the philosophy is that conformal therapy will allow higher doses to be delivered to tumour without a parallel increased risk of morbidity, then the hypothesis must be tested in two stages. Firstly, 
